APH vs ATXS · P/E 40, rev $16.38B vs rev $706.0K
Amphenol Corporation (APH) versus Astria Therapeutics Inc (ATXS) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Latest reported APH revenue for 2026-06-30 was $16.38B. Net income was $2.70B. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. ATXS currently screens at market cap $382.1M.
Not investment advice. Open the APH and ATXS stock pages for the full models.
Not investment advice.